| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 2 |
| NetGPI | no | yes: 0, no: 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000786 | nucleosome | 3 | 3 |
| GO:0032991 | protein-containing complex | 1 | 3 |
| GO:0032993 | protein-DNA complex | 2 | 3 |
| GO:0044815 | DNA packaging complex | 2 | 3 |
Related structures:
AlphaFold database: A4I2S4
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006325 | chromatin organization | 4 | 3 |
| GO:0006334 | nucleosome assembly | 7 | 3 |
| GO:0006338 | chromatin remodeling | 5 | 3 |
| GO:0009987 | cellular process | 1 | 3 |
| GO:0016043 | cellular component organization | 3 | 3 |
| GO:0022607 | cellular component assembly | 4 | 3 |
| GO:0034728 | nucleosome organization | 6 | 3 |
| GO:0043933 | protein-containing complex organization | 4 | 3 |
| GO:0065003 | protein-containing complex assembly | 5 | 3 |
| GO:0065004 | protein-DNA complex assembly | 6 | 3 |
| GO:0071824 | protein-DNA complex subunit organization | 5 | 3 |
| GO:0071840 | cellular component organization or biogenesis | 2 | 3 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 3 |
| GO:0003677 | DNA binding | 4 | 3 |
| GO:0005198 | structural molecule activity | 1 | 3 |
| GO:0005488 | binding | 1 | 3 |
| GO:0030527 | structural constituent of chromatin | 2 | 3 |
| GO:0097159 | organic cyclic compound binding | 2 | 3 |
| GO:1901363 | heterocyclic compound binding | 2 | 3 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 49 | 51 | PF00675 | 0.766 |
| CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.704 |
| CLV_PCSK_SKI1_1 | 57 | 61 | PF00082 | 0.729 |
| CLV_PCSK_SKI1_1 | 65 | 69 | PF00082 | 0.555 |
| CLV_PCSK_SKI1_1 | 73 | 77 | PF00082 | 0.522 |
| CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.520 |
| CLV_PCSK_SKI1_1 | 89 | 93 | PF00082 | 0.509 |
| CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.499 |
| DOC_CKS1_1 | 52 | 57 | PF01111 | 0.763 |
| DOC_USP7_UBL2_3 | 27 | 31 | PF12436 | 0.686 |
| DOC_USP7_UBL2_3 | 32 | 36 | PF12436 | 0.691 |
| DOC_USP7_UBL2_3 | 37 | 41 | PF12436 | 0.709 |
| DOC_USP7_UBL2_3 | 42 | 46 | PF12436 | 0.764 |
| DOC_USP7_UBL2_3 | 47 | 51 | PF12436 | 0.701 |
| DOC_USP7_UBL2_3 | 56 | 60 | PF12436 | 0.572 |
| DOC_USP7_UBL2_3 | 61 | 65 | PF12436 | 0.496 |
| DOC_USP7_UBL2_3 | 68 | 72 | PF12436 | 0.577 |
| DOC_USP7_UBL2_3 | 73 | 77 | PF12436 | 0.509 |
| DOC_USP7_UBL2_3 | 80 | 84 | PF12436 | 0.482 |
| DOC_USP7_UBL2_3 | 85 | 89 | PF12436 | 0.503 |
| DOC_USP7_UBL2_3 | 92 | 96 | PF12436 | 0.455 |
| DOC_USP7_UBL2_3 | 97 | 101 | PF12436 | 0.487 |
| DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.715 |
| DOC_WW_Pin1_4 | 21 | 26 | PF00397 | 0.534 |
| DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.764 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.676 |
| LIG_SH3_2 | 55 | 60 | PF14604 | 0.755 |
| LIG_SH3_3 | 49 | 55 | PF00018 | 0.652 |
| LIG_SH3_4 | 57 | 64 | PF00018 | 0.749 |
| LIG_SH3_4 | 69 | 76 | PF00018 | 0.573 |
| LIG_SH3_4 | 81 | 88 | PF00018 | 0.569 |
| LIG_SH3_4 | 89 | 96 | PF00018 | 0.447 |
| MOD_CDC14_SPxK_1 | 16 | 19 | PF00782 | 0.735 |
| MOD_CDC14_SPxK_1 | 24 | 27 | PF00782 | 0.654 |
| MOD_CDK_SPK_2 | 17 | 22 | PF00069 | 0.750 |
| MOD_CDK_SPK_2 | 51 | 56 | PF00069 | 0.764 |
| MOD_CDK_SPxK_1 | 13 | 19 | PF00069 | 0.722 |
| MOD_CDK_SPxK_1 | 21 | 27 | PF00069 | 0.536 |
| MOD_CDK_SPxK_1 | 51 | 57 | PF00069 | 0.764 |
| MOD_CK1_1 | 2 | 8 | PF00069 | 0.663 |
| MOD_CK1_1 | 20 | 26 | PF00069 | 0.756 |
| MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.602 |
| MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.660 |
| MOD_GSK3_1 | 17 | 24 | PF00069 | 0.514 |
| MOD_GSK3_1 | 8 | 15 | PF00069 | 0.683 |
| MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.722 |
| MOD_ProDKin_1 | 21 | 27 | PF00069 | 0.536 |
| MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.764 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3S7X0Q1 | Leishmania donovani | 98% | 100% |